Sarepta Therapeutics Inc (SRPT)

Return on equity (ROE)

		Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019
Net income (ttm)	US$ in thousands	16,897	-535,977	-690,876	-907,677	-1,115,218	-703,488	-716,225	-506,631	-356,555	-418,780	-486,116	-634,471	-703,886	-554,128	-600,514	-530,341	-655,924	-715,075	-620,267	-570,334
Total stockholders’ equity	US$ in thousands	961,192	859,337	764,357	741,411	712,749	384,950	430,840	726,457	856,886	928,009	469,528	485,108	535,445	761,759	892,047	1,042,870	1,144,830	818,187	995,204	1,099,170
ROE		1.76%	-62.37%	-90.39%	-122.43%	-156.47%	-182.75%	-166.24%	-69.74%	-41.61%	-45.13%	-103.53%	-130.79%	-131.46%	-72.74%	-67.32%	-50.85%	-57.29%	-87.40%	-62.33%	-51.89%

March 31, 2024 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $16,897K ÷ $961,192K
= 1.76%

The return on equity (ROE) for Sarepta Therapeutics Inc has shown significant fluctuations over the periods indicated in the table.

Starting from December 2019 to March 2024, the ROE has been negative, indicating that the company has been generating losses in relation to its equity. The ROE reached its lowest point in the recent quarters, with values as low as -182.75% in December 2022 and -156.47% in March 2023.

A negative ROE can suggest inefficiency in the utilization of equity investments to generate profits, potentially stemming from operational challenges, high debt levels, or other financial difficulties.

Investors and analysts closely monitor ROE as it provides insights into how effectively a company is utilizing its equity to generate profits, and the negative trend displayed by Sarepta Therapeutics Inc raises concerns about the company's financial performance and long-term sustainability. Further analysis of the company's financial statements and operational strategies would be necessary to understand the factors contributing to the negative ROE trend.